NCT01180062 - Safety Study of Latanoprost Slow Release Insert | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions

Primary Open Angle Glaucoma (POAG)Ocular Hypertension (OHT)

Interventions

DRUG

Latanoprost

"Group 1 will be given a single, low dose Latanoprost SR insert that contains a daily dose of 0.5µg Latanoprost.~Group 2 will be given two, low dose Latanoprost SR inserts that contain a combined daily dose of 1.0µg Latanoprost.~Duration of drug release is expected to be 3-6 months.~Group 3 will be given a single, low dose Latanoprost SR insert that contains a daily dose of 2.0µg Latanoprost."

DRUG

Arm 2

Group 2 will be given two, low dose Latanoprost SR inserts that contain a combined daily dose of 1.0µg Latanoprost.

DRUG

Latanoprost SR insert

Group 3 will be given a single, low dose Latanoprost SR insert that contains a daily dose of 2.0µg Latanoprost.

Trial Locations (1)

40546

Univ of Ky Dept of Ophthalmology and Visual Sciences, Lexington